European Journal of Heart Failure

Journal

Publication Venue For

  • Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans.  23:1290-1295. 2021
  • Sodium–glucose co-transporter 2 inhibitors: strength of evidence for a cardio-renal-metabolic therapy.  23:1009-1011. 2021
  • Using antimatter to uncover what matters: metformin effects on myocardial efficiency in heart failure.  22:1638-1640. 2020
  • Anti-inflammatory diet and risk of heart failure: two prospective cohort studies.  22:676-682. 2020
  • Impact of pulmonary disease on the prognosis in heart failure with preserved ejection fraction: the TOPCAT trial.  22:557-559. 2020
  • Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta-analysis.  22:472-485. 2020
  • Application of the H2FPEF score to a global clinical trial of patients with heart failure with preserved ejection fraction: the TOPCAT trial.  21:1288-1291. 2019
  • The association of retinal vessel calibres with heart failure and long-term alterations in cardiac structure and function: the Atherosclerosis Risk in Communities (ARIC) Study.  21:1207-1215. 2019
  • Adiposity, body composition and ventricular–arterial stiffness in the elderly: the Atherosclerosis Risk in Communities Study.  20:1191-1201. 2018
  • Left ventricular ejection time is an independent predictor of incident heart failure in a community-based cohort.  20:1106-1114. 2018
  • Influence of ejection fraction on cause-specific mortality in heart failure with preserved ejection fraction.  20:815-816. 2018
  • Central sleep apnoea in heart failure with reduced ejection fraction, adaptive servo-ventilation, and left ventricular ejection fraction: the (still) missing link.  20:545-547. 2018
  • Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.  20:359-369. 2018
  • Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?.  20:317-322. 2018
  • The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial.  19:1545-1550. 2017
  • High prevalence of subclinical cerebral infarction in patients with heart failure with preserved ejection fraction.  19:1303-1309. 2017
  • Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction.  19:1043-1052. 2017
  • Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure—does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS).  19:739-747. 2017
  • Remote haemodynamic-guided care for patients with chronic heart failure: a meta-analysis of completed trials.  19:426-433. 2017
  • Left ventricular deformation at rest predicts exercise-induced elevation in pulmonary artery wedge pressure in patients with unexplained dyspnoea.  19:101-110. 2017
  • Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) Study.  18:629-637. 2016
  • Fruit and vegetable intake and rate of heart failure: A population-based prospective cohort of women.  17:20-26. 2015
  • Impact of lowering pulmonary vascular resistance on right and left ventricular deformation in pulmonary arterial hypertension.  17:63-73. 2015
  • Worsening heart failure, a critical event during hospital admission for acute heart failure: Results from the VERITAS study.  16:1362-1371. 2014
  • Does increased oxygen extraction contribute to the improvement of VO2peak observed in patients who exercise with increased LVAD speed?.  16:1256. 2014
  • Impaired left atrial function in heart failure with preserved ejection fraction.  16:1096-1103. 2014
  • Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction.  16:535-542. 2014
  • Clinicians' attitudes regarding withdrawal of left ventricular assist devices in patients approaching the end of life.  15:1262-1266. 2013
  • Effect of oral digoxin in high-risk heart failure patients: A pre-specified subgroup analysis of the DIG trial.  15:551-559. 2013
  • Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: A propensity-matched inception cohort clinical effectiveness study.  14:1179-1188. 2012
  • Treatment of functional mitral regurgitation by percutaneous annuloplasty: Results of the TITAN Trial.  14:931-938. 2012
  • Impairment of activities of daily living and incident heart failure in community-dwelling older adults.  14:581-587. 2012
  • Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren.  14:185-192. 2012
  • Hypoalbuminaemia and incident heart failure in older adults.  13:1078-1086. 2011
  • Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure.  13:551-559. 2011
  • Relationship between left and right ventricular ejection fractions in chronic advanced systolic heart failure: Insights from the BEST trial.  13:392-397. 2011
  • Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: A propensity-matched study.  13:200-206. 2011
  • The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction.  12:1229-1237. 2010
  • Editorial: A unified view of ventricular remodelling.  12:779-781. 2010
  • Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium.  10:1065-1072. 2008
  • Dissociation between gene and protein expression of metabolic enzymes in a rodent model of heart failure.  8:687-693. 2006
  • Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction.  8:409-419. 2006
  • Incident atrial fibrillation and mortality in older adults with heart failure.  7:1118-1121. 2005
  • Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure.  6:421-426. 2004
  • International Standard Serial Number (issn)

  • 1388-9842
  • Electronic International Standard Serial Number (eissn)

  • 1879-0844